reports
AKZO NOBEL INDIA sees a downgrade to Neutral on account of less fundam...
The independent financial analyst theScreener just lowered the general evaluation of AKZO NOBEL INDIA (IN), active in the Speciality Chemicals industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered defensive. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Neutral. As of the analysis date July 23, 2021, the closing price was INR 2,288.85 and its ...
- Mehul Desai
Akzo Nobel India's Q2FY20 results (Neutral) - Weak performance…
Q2FY20 result highlights Akzo Nobel’s Net sales degrew by 11.2% yoy to Rs 6.3bn (est: Rs7.3bn), EBITDA grew by 12% yoy to Rs728m (est: Rs841m), PAT increased by 34% yoy to Rs493m (est: Rs615m). Gross margins were up 420bps yoy basis at 47.2% aided by benign input cost. Staff cost decreased by 4% yoy and other expenses decreased by 7% yoy. Resultant EBITDA was up by 12% yoy with a margin expansion of 240bps to 11.5%. Adjusting for IND AS 116 benefit, EBITDA was up 4.3% yoy to Rs680m, with a ...
- Mehul Desai
Akzo Nobel India's Q1FY20 results (Neutral) - Revenue disappointment c...
Q1FY20 result highlights Akzo Nobel’s Net sales grew by 0.6% yoy to Rs 7.2bn (est: Rs7.3bn), EBITDA grew by 43% yoy to Rs1.03bn (est: Rs1.08m), PAT increased by 31% yoy to Rs571m (est: Rs650m). Gross margins were up 300bps yoy basis at 45.2% aided by benign input cost & improved mix. Staff cost decreased by 8% yoy and other expenses decreased by 0.8% yoy. Resultant EBITDA was up by 43% yoy with a margin expansion of 430bps to 14.4%. Adjusting for IND AS 116, benefit EBITDA was up 35% yoy to...
- Mehul Desai
Akzo Nobel India's Q4FY19 results (Neutral) - Revenue disappoints, tig...
Q4FY19 result highlights Akzo Nobel’s Net sales increased by 0.7% yoy to Rs 7.05bn (est: Rs7.7bn), EBITDA increased by 48% yoy to Rs1.04bn (est: Rs871m), PAT increased by 54% yoy to Rs703m (est:Rs527m). Coatings revenues were flat for the quarter. Adj for promotional expense of Rs143m in 4QFY19, LTL growth was 3%. EBIT grew by 81% yoy with a margin expansion of 630bps yoy. Gross margins were flat on yoy basis at 42.7% with impact of higher input costs offset by better mix. Staff cost decrea...
Akzo Nobel India's Q3FY19 results (Neutral) - Earnings trajectory rema...
Q3FY19 result highlights Akzo Nobel’s Net sales increased by 10% yoy to Rs 7.8bn (est: Rs7.8bn), EBITDA increased by 2.2% yoy to Rs1.0bn (est: Rs1.1bn), PAT decreased by 24% yoy to Rs604m (est:Rs712m). Coatings revenues in creased by 9% yoy. EBIT grew by 5.3% yoy with a margin decline of 40bps yoy. Gross margins declined by 220bps yoy to 40.6% impacted by higher input costs and rupee depreciation. Staff cost increased by 2% yoy and other expenses increased by 8.5% yoy. Resultant EBITDA was...
Akzo Nobel India's Q2FY19 results (Neutral) - Earnings delivery remain...
Q2FY19 result highlights Akzo Nobel’s Net sales increased by 8.4% yoy to Rs 7.1bn (est: Rs7.3bn), EBITDA increased by 4.3% yoy to Rs652m (est:Rs586m), Adjusted PAT decreased by 6% yoy to Rs363m. Gross margins declined by 350bps yoy to 43% impacted by unfavourable sales mix, higher input costs and rupee depreciation. Staff cost increased by 3% yoy and other expenses decreased by 2% yoy. Resultant EBITDA was up by 4% yoy with a margin decline of 40bps to 9.1%. Other income increased by 4% yo...
Akzo Nobel India's Q1FY19 results (Neutral) - Revenue growth continues...
Q1FY19 result highlights Akzo Nobel’s base quarter results are restated to exclude the chemical business. Net sales increased by 10.4% yoy to Rs 7.15bn, EBITDA increased by 9.9% yoy to Rs724.5m, Adjusted PAT increased by 11% yoy to Rs435m. Adjusting for excise, comparable sales for Coatings segments were up by 10% yoy. Gross margins declined by 160bps yoy to 42.2% impacted by higher input costs. Staff cost increased by 14.3% yoy and other expenses increased by 1.3%Resultant EBITDA was up by...
Akzo Nobel India's Q4FY18 results (Neutral) - Higher input costs drags...
Q4FY18 result highlights Akzo Nobel’s base quarter results are restated to exclude the chemical business. Net sales increased by 10.3% yoy to Rs 7bn, EBITDA declined by 6.5% yoy to Rs 699m, PAT decreased by 33% yoy to Rs462m. On reported basis, Coatings sales declined by 1.6% yoy to Rs7bn. Adjusting for excise, comparable sales were up by 10% yoy. Gross margins declined by 320bps yoy to 42.6% impacted by higher input costs. Staff cost increased by 18.8% yoy and other expenses decreased by 0...
Akzo Nobel India's Q3FY18 results (Neutral) - Continues to lag behind ...
Q3FY18 result highlights Akzo Nobel’s base quarter results are restated to exclude the chemical business. Net sales increased by 5.8% to Rs 7bn, EBITDA declined by 1.6% to Rs 638m, PAT increased by 18.7% yoy to Rs796m. On reported basis, Coatings sales declined by 5% yoy to Rs7bn. Adjusting for excise, comparable sales were up by 6% yoy. We believe the revenue growth would have been an equal mix of volume and value, implying a 3-4% volume growth. Gross margins declined by 210bps yoy to 42.8...
Event update: Akzo Nobel India (Neutral) - Sale of chemical business l...
Event Akzo Nobel India Ltd has announced sale of its specialty Chemical business to an affiliate of Akzo Nobel group. Key details The sale of chemical business will result in proceeds of Rs3.2bn, subject to adjustment for working capital and for an economic effective date of 1 January 2018. The transaction involves transfer of the Mahad polymer manufacturing facility, chemical trading business and 80 employees related to the chemical division. The management expects transaction to be ...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.